Who has invested in Vicebio?

TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio, UniQuest, Medicxi are named among the investors backing Vicebio.

Vicebio Funding: $100M Raised, Series B (2024)

Vicebio funding overview

Vicebio is based in London, UK. Vicebio has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for Vicebio runs through 2024; nothing later has been disclosed. Investors on record include TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio, UniQuest, Medicxi. 6 distinct backers are named across the disclosed rounds.

Vicebio at a glance

Total raised: $100M
Latest round: Series B
Latest round date: September 2024
Headquarters: London, UK
Notable investors: TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio, UniQuest, Medicxi

Frequently asked about Vicebio funding

How much has Vicebio raised?: Vicebio has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Vicebio?: TCGX, Goldman Sachs Alternatives, Avoro Ventures, venBio, UniQuest, Medicxi are named among the investors backing Vicebio.
What was the latest Vicebio funding round?: The most recent disclosed round is a Series B, announced in September 2024.
Where is Vicebio based?: Vicebio is based in London, UK.
When did Vicebio last raise?: The last disclosed Vicebio round closed in September 2024 at Series B.

We update the Vicebio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in London and their backers are listed below.

Vicebio Funding: $100M Raised, Series B (2024)

Vicebio funding overview

Vicebio at a glance

Frequently asked about Vicebio funding

Companies related to Vicebio (32)

Browse related funding lists (9)